Australia - on lockdown amid 2nd wave of COVID-19 #coronavirus: ABC News 9.5M subscribers

Harvard Global Health Institute’s Dr. Ashish Jha talks with “GMA” about whether the U.S. needs to do a lockdown similar to Australia’s.

ABC News

9.5M subscribers

Brazil - Covid-19 cases pass 500,000 mark, Bolsonaro rallies, US sends unproven drug #hydroxychloroquine: FRANCE 24 English 1.26M subscribers

President Jair Bolsonaro, who opposes coronavirus lockdown measures imposed by Brazilian cities and states, rallied with his supporters Sunday, as Washington said it had sent two million doses of a controversial unproven Covid-19 drug. 

BREAKING: New study finds HCQ +AZ (or other antibiotic) significantly reduces time to viral clearance and hospital stay in moderate covid-19 patients compared to both conservative treatment and Lopinavir-ritonavir.https://t.co/FnCpMhy2R0 pic.twitter.com/fTVpVAsERB

— Hydroxychloroquine News (@niro60487270) May 19, 2020

Investigation of Surgisphere by data scientist @ellis2013nz

"the data represents treatment and health outcomes of 96,032 patients from 671 hospitals in six continents...there is simply no plausible way I can think of that the data are real."#LancetGate https://t.co/2ziesbagGb

— James Todaro, MD (@JamesTodaroMD) May 30, 2020

Questions persist about Surgisphere, the company that produced the Lancet study that resulted in the halting of HCQ use for Covid-19 around the world.https://t.co/yPbjMZlbGk

— Hydroxychloroquine News (@niro60487270) May 31, 2020

The Lancet study on hydroxychloroquine is going down in flames. 🔥 🔥🔥

Remember the WHO halted hydroxychloroquine trials worldwide over this study, after reviewing the data for a mere 48-72 hours over a weekend.

— James Todaro, MD (@JamesTodaroMD) May 29, 2020

FRANCE 24 English

1.26M subscribers